A carregar...

A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer

This study investigated the maximum tolerated dose of S-1 based on the frequency of its dose-limiting toxicities (DLT) with concurrent radiotherapy in patients with locally advanced pancreatic cancer. S-1 was administered orally at escalating doses from 50 to 80 mg m(−2) b.i.d. on the day of irradia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ikeda, M, Okusaka, T, Ito, Y, Ueno, H, Morizane, C, Furuse, J, Ishii, H, Kawashima, M, Kagami, Y, Ikeda, H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359907/
https://ncbi.nlm.nih.gov/pubmed/17533388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!